Wilson Sonsini Goodrich & Rosati represented OneStream on the offering. OneStream, Inc. (Nasdaq: OSTO) (‘OneStream’), the leading enterprise finance management platform that modernizes the Office of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised LuxWall on IP and patent strategy for the transaction. LuxWall, a leader in glass-based transparent insulation solutions to reduce energy...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Stepful in the transaction. Stepful, an AI-powered learning platform for healthcare roles, announced it raised $31.5 million in Series B...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Fastino in the transaction. Fastino, a new foundation AI model provider, has emerged from stealth to announce its launch and...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Merck on the transaction and Wilson Sonsini Goodrich & Rosati advised LaNova Medicines. Merck (NYSE: MRK), known as MSD outside of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Radical Ventures on the transaction. Writer, Inc. (‘Writer’), the full-stack generative AI platform for the enterprise, announced $200 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised 11x on the transaction. 11x, the leader in AI-powered digital workers for revenue teams, announced the closing of a $50...
You must be a Standard 1 Year member to access this content.
Orrick represented Ipsen in the transaction. Ipsen, a global biopharmaceutical company with a focus on bringing transformative medicines to patients in oncology, rare diseases and neuroscience,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented LendAPI in the transaction. LendAPI, an innovative fintech start-up transforming financial technology deployment, raised $3.2 million in seed funding. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represents Pacific Biosciences of California, Inc. on the transaction. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB), a leading developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MoradaUno on the transaction. MoradaUno announced raising $5.6 million in a Series A financing round co-led by Flourish Ventures and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction. IonQ (NYSE: IONQ), a leader in quantum computing, announced that it has reached a definitive agreement...
You must be a Standard 1 Year member to access this content.
